Alithea Genomics
Lausanne, CH · Founded 2020 · 34 employees on LinkedIn · 4 known investors
Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development. The company's plate-based, high-throughput solutions reduce costs, hands-on time, and environmental impact compared to standard RNA-seq practices.
Founders & leadership
Alithea Genomics was founded in 2020 by Riccardo Dainese and Daniel Alpern.
Investors · 4
Also in the syndicate · 2
Genku VenturesleadZürcher Kantonalbank
Funding
SEC filings, press & company announcements$3.9M disclosed across 1 round · 2026
- $3.9MSeed RoundMar 2026 · 4 sources
Genku Ventures (lead), Novalis Biotech, Zürcher Kantonalbank
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Alithea Genomics do?
- Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development. The company's plate-based, high-throughput solutions reduce costs, hands-on time, and environmental impact compared to standard RNA-seq practices.
- Who founded Alithea Genomics?
- Alithea Genomics was founded by Riccardo Dainese, Daniel Alpern in 2020.
- Who are Alithea Genomics's investors?
- Alithea Genomics's investors include Kickfund, Novalis Biotech.
- How much funding has Alithea Genomics raised?
- Alithea Genomics has disclosed $3.9M raised across 1 round.
- Where is Alithea Genomics headquartered?
- Alithea Genomics is headquartered in Lausanne, CH.